Targeting the mTOR Pathway in Tumor Malignancy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|13|3|267-277

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.13, Iss.3, 2013-03, pp. : 267-277

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insights into melanoma: targeting the mTOR pathway for therapeutics

By Pópulo Helena   Soares Paula   Lopes José Manuel  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 7, 2012-07 ,pp. : 689-705

Informa Healthcare

Access to resources Recommend Favorite

Targeting mTOR Signaling Pathway in Ovarian Cancer

By  

Current Medicinal Chemistry, Vol. 18, Iss. 19, 2011-06 ,pp. : 2960-2968

Bentham Science Publishers

Access to resources Recommend Favorite

mTOR Pathway and mTOR Inhibitors as Agents for Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 8, Iss. 8, 2008-12 ,pp. : 647-665

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting mTOR Pathways in Human Malignancies

By  

Current Pharmaceutical Design, Vol. 18, Iss. 19, 2012-06 ,pp. : 2766-2777

Bentham Science Publishers

Access to resources Recommend Favorite

An overview of the mTOR pathway as a target in cancer therapy

By Gentzler Ryan D   Altman Jessica K   Platanias Leonidas C  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 5, 2012-05 ,pp. : 481-489

Informa Healthcare

Access to resources Recommend Favorite